BRECCIA, MARTINA
BRECCIA, MARTINA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice
2024 D. Pozzer, M. Indrigo, M. Breccia, E. Florio, C.A. Franchino, G. De Rocco, F. Maltecca, A. Fadda, M. Rossato, A. Aramini, M. Allegretti, A. Frasca, L. De Filippis, N. Landsberger
Mecp2 knock-out astrocytes affect synaptogenesis by Interleukin 6 dependent mechanisms
2024 E. Albizzati, M. Breccia, E.M. Florio, C. Cabasino, F.M. Postogna, R. Grassi, E. Boda, C. Battaglia, C. DE PALMA, C. De Quattro, D. Pozzi, N. Landsberger, A. Frasca
GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation
2024 M. Fazzari, G. Lunghi, E.V. Carsana, M. Valsecchi, E. Spiombi, M. Breccia, S.R. Casati, S. Pedretti, N. Mitro, L. Mauri, M.G. Ciampa, S. Sonnino, N. Landsberger, A. Frasca, E. Chiricozzi
MeCP2 deficiency in astrocytes alters synaptogenesis: new insights on Rett syndrome
2023 M. Breccia, E. Albizzati, E. Florio, C. Cabasino, D. Pozzi, E. Boda, C. Battaglia, C. De Palma, C. De Quattro, N. Landsberger, A. Frasca
The detrimental effect of Mecp2 null astrocytes on synapses: exploring the molecular mechanisms to find novel druggable targets for Rett syndrome
2023 E. Albizzati, E.M. Florio, M. Breccia, C. Cabasino, D. Pozzi, E. Boda, C. Battaglia, C. DE PALMA, Concetta De Quattro, N. Landsberger, A. Frasca
MeCP2 deficiency in astrocytes alters synaptogenesis: new insights on Rett syndrome
2022 E. Albizzati, E.M. Florio, M. Breccia, C. Cabasino, D. Pozzi, C. DE PALMA, N. Landsberger, A. Frasca
Obesity is a risk factor for acute promyelocytic leukemia: Evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism
2020 L. Mazzarella, E. Botteri, A. Matthews, E. Gatti, D. Di Salvatore, V. Bagnardi, M. Breccia, P. Montesinos, T. Bernal, C. Gil, T.J. Ley, M. Sanz, K. Bhaskaran, F.L. Coco, P.G. Pelicci